These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 108205)
1. Modification of the anti-tumour immune response by suppressor gene products of lymphoid cells. De Giorgi L; Matossian-Rogers A; Festenstein H Immunology; 1979 Apr; 36(4):711-8. PubMed ID: 108205 [TBL] [Abstract][Full Text] [Related]
2. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells. Sensi ML; Parenza M; Parmiani G J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938 [TBL] [Abstract][Full Text] [Related]
3. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity. Maier T; Holda JH; Claman HN J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774 [TBL] [Abstract][Full Text] [Related]
4. Genetic determination of the immune response in mice to cells of different histological type. Lavrovsky VA; Viksler VK; Yurchenko YA; Razvorotnev VA Immunology; 1979 Apr; 36(4):835-41. PubMed ID: 108209 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. VI. Detection of a non-MHC gene(s) in the E alpha-bearing RIIIS mouse strain that is associated with a specific lack of T cell responses to the M. arthritidis soluble mitogen. Cole BC; Tuller JW; Sullivan GJ J Immunol; 1987 Aug; 139(3):927-35. PubMed ID: 3110289 [TBL] [Abstract][Full Text] [Related]
7. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response. Gordon WC; Prager MD Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275 [TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype. Lynch DH; Daynes RA; Hodes RJ J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117 [TBL] [Abstract][Full Text] [Related]
9. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice. Anderson GD; Banerjee S; Luthra HS; David CS J Immunol; 1991 Aug; 147(4):1189-93. PubMed ID: 1907992 [TBL] [Abstract][Full Text] [Related]
10. Regulation of immune responses by T cell subsets. Role of helper and suppressor T cells in the development and expression of MHC-restricted antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X responder)F1 spleen cells. Lake JP; Kapp JA; Pierce CW J Immunol; 1986 Feb; 136(4):1201-9. PubMed ID: 2418108 [TBL] [Abstract][Full Text] [Related]
11. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression. Ishikawa H; Saito K; Kubota E J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225 [TBL] [Abstract][Full Text] [Related]
12. Association of the lymphoproliferative disease inducer gene Arp with autoimmunity and resistance to tumour growth. Matossian-Rogers A Clin Exp Immunol; 1985 Sep; 61(3):614-23. PubMed ID: 2416497 [TBL] [Abstract][Full Text] [Related]
13. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals. Henderson LA; Ciavarra R; Riblet R; Forman J J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638 [TBL] [Abstract][Full Text] [Related]
14. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response. Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798 [TBL] [Abstract][Full Text] [Related]
15. Essential requirement of I-A region-identical host bone marrow or bone marrow-derived cells for tumor neutralization by primed L3T4+ T cells. Ozawa H; Iwaguchi T; Kataoka T J Immunol; 1987 Dec; 139(11):3896-901. PubMed ID: 2960743 [TBL] [Abstract][Full Text] [Related]
16. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro. Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374 [TBL] [Abstract][Full Text] [Related]
17. Specific haplotype preference in congenic F1 hybrid mice in the cytotoxic T cell response to the male specific antigen H-Y. Müllbacher A; Sheena JH; Fierz W; Brenan M J Immunol; 1981 Aug; 127(2):686-9. PubMed ID: 6166683 [TBL] [Abstract][Full Text] [Related]
18. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice. Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461 [TBL] [Abstract][Full Text] [Related]
19. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential. Ishikawa H; Kubota E; Saito K J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314 [TBL] [Abstract][Full Text] [Related]
20. Syngeneic responses by murine thymocytes: a role for non-MHC and non-MLS genes. Wu S; Thomas DW J Immunol; 1985 Jan; 134(1):10-5. PubMed ID: 3155457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]